PIN3 LINEZOLID FOR THE TREATMENT OF SKIN AND SOFT-TISSUE MRSA INFECTIONS-A COST-EFFECTIVE ALTERNATIVE TO VANCOMYCIN- EVIDENCE FROM A MULTINATIONAL CLINICAL TRIAL
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)66020-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)66020-2/fulltext
Title :
PIN3 LINEZOLID FOR THE TREATMENT OF SKIN AND SOFT-TISSUE MRSA INFECTIONS-A COST-EFFECTIVE ALTERNATIVE TO VANCOMYCIN- EVIDENCE FROM A MULTINATIONAL CLINICAL TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66020-2&doi=10.1016/S1098-3015(10)66020-2
First page :
Section Title :
Open access? :
No
Section Order :
387